Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I
about
Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.siRNA Therapeutics for Primary Hyperoxaluria: A Beginning.Molecular therapy of primary hyperoxaluria.Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria.Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.
P2860
Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glycolate Oxidase Is a Safe an ...... f Primary Hyperoxaluria Type I
@en
type
label
Glycolate Oxidase Is a Safe an ...... f Primary Hyperoxaluria Type I
@en
prefLabel
Glycolate Oxidase Is a Safe an ...... f Primary Hyperoxaluria Type I
@en
P2860
P921
P356
P1433
P1476
Glycolate Oxidase Is a Safe an ...... f Primary Hyperoxaluria Type I
@en
P2093
Eduardo Salido
P2860
P304
P356
10.1038/MT.2015.224
P407
P577
2015-12-22T00:00:00Z